Breaking News Instant updates and real-time market news.

IART

Integra LifeSciences

$55.79 /

+0.4 (+0.72%)

10:55
03/29/19
03/29
10:55
03/29/19
10:55

Integra LifeSciences participates in a conference call with JPMorgan

Medical Supplies & Devices Analyst Marcus hosts a conference call with CEO Wilkinson on March 29 at 12 pm hosted by JPMorgan.

  • 29

    Mar

IART Integra LifeSciences
$55.79 /

+0.4 (+0.72%)

03/11/19 Piper Sandler
Integra warning letter 'not the end of the world,' says Piper Jaffray
02/21/19
Piper reiterates Overweight rating on Integra after Q4 earnings
01/03/19 Truist
Integra LifeSciences initiated with a Buy at SunTrust
12/17/18 Credit Suisse
Integra LifeSciences initiated with an Outperform at Credit Suisse

TODAY'S FREE FLY STORIES

Recommendations
Air Products price target raised to $325 from $315 at Wells Fargo » 07:25
09/29/20
09/29
07:25
09/29/20
07:25
APD

Air Products

$292.24 /

+1.59 (+0.55%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APD Air Products
$292.24 /

+1.59 (+0.55%)

APD Air Products
$292.24 /

+1.59 (+0.55%)

09/21/20 Evercore ISI
Air Products initiated with an Outperform at Evercore ISI
08/14/20 BMO Capital
Air Products price target raised to $363 from $359 at BMO Capital
07/31/20 JPMorgan
Linde upgraded to Overweight after 'remarkable' Q2 at JPMorgan
07/28/20 Morgan Stanley
Linde plc price target raised to $275 from $205 at Morgan Stanley
APD Air Products
$292.24 /

+1.59 (+0.55%)

APD Air Products
$292.24 /

+1.59 (+0.55%)

APD Air Products
$292.24 /

+1.59 (+0.55%)

Hot Stocks
Summit Therapeutics ceasing work on gonorrhea program » 07:24
09/29/20
09/29
07:24
09/29/20
07:24
SMMT

Summit Therapeutics

$3.41 /

+0.04 (+1.19%)

Based on results from…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMMT Summit Therapeutics
$3.41 /

+0.04 (+1.19%)

SMMT Summit Therapeutics
$3.41 /

+0.04 (+1.19%)

03/19/20 H.C. Wainwright
Summit Therapeutics assumed with a Buy at H.C. Wainwright
SMMT Summit Therapeutics
$3.41 /

+0.04 (+1.19%)

Hot Stocks
Summit withdraws commentary on timing of completion of Phase 3 Ri-CoDIFy trials » 07:24
09/29/20
09/29
07:24
09/29/20
07:24
SMMT

Summit Therapeutics

$3.41 /

+0.04 (+1.19%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMMT Summit Therapeutics
$3.41 /

+0.04 (+1.19%)

SMMT Summit Therapeutics
$3.41 /

+0.04 (+1.19%)

03/19/20 H.C. Wainwright
Summit Therapeutics assumed with a Buy at H.C. Wainwright
SMMT Summit Therapeutics
$3.41 /

+0.04 (+1.19%)

Recommendations
Analog Devices price target lowered to $150 from $155 at KeyBanc » 07:23
09/29/20
09/29
07:23
09/29/20
07:23
ADI

Analog Devices

$116.99 /

+3.55 (+3.13%)

KeyBanc analyst John Vinh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADI Analog Devices
$116.99 /

+3.55 (+3.13%)

ADI Analog Devices
$116.99 /

+3.55 (+3.13%)

08/24/20 Citi
Analog Devices price target raised to $134 from $120 at Citi
08/20/20 Baird
Analog Devices should be owned as a defensive play, says Baird
08/20/20 RBC Capital
Analog Devices price target raised to $135 from $130 at RBC Capital
08/20/20 Goldman Sachs
Analog Devices price target raised to $150 from $142 at Goldman Sachs
ADI Analog Devices
$116.99 /

+3.55 (+3.13%)

ADI Analog Devices
$116.99 /

+3.55 (+3.13%)

ADI Analog Devices
$116.99 /

+3.55 (+3.13%)

ADI Analog Devices
$116.99 /

+3.55 (+3.13%)

Hot Stocks
Ironwood to discontinue IW-3718 development, reduce headcount by 35% » 07:22
09/29/20
09/29
07:22
09/29/20
07:22
IRWD

Ironwood

$9.52 /

+0.06 (+0.63%)

Ironwood announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRWD Ironwood
$9.52 /

+0.06 (+0.63%)

IRWD Ironwood
$9.52 /

+0.06 (+0.63%)

06/17/20 Northland
Northland starts Ironwood at Outperform, sees long runway for Linzess
06/17/20 Northland
Ironwood initiated with an Outperform at Northland
IRWD Ironwood
$9.52 /

+0.06 (+0.63%)

IRWD Ironwood
$9.52 /

+0.06 (+0.63%)

Recommendations
Aducanumab AdComm could drive Biogen up or down 20%-30%, says Morgan Stanley » 07:21
09/29/20
09/29
07:21
09/29/20
07:21
BIIB

Biogen

/

+

After the FDA announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
/

+

BIIB Biogen
/

+

09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/18/20 RBC Capital
Biogen price target lowered to $277 from $284 at RBC Capital
09/17/20 Morgan Stanley
Court ruling eliminates hurdle for Tecfidera generics, says Morgan Stanley
09/16/20 Raymond James
Mylan exclusivity on Tecfidera generic abruptly ending, says Raymond James
BIIB Biogen
/

+

BIIB Biogen
/

+

BIIB Biogen
/

+

BIIB Biogen
/

+

BIIB Biogen
/

+

Initiation
Stoke Therapeutics initiated with a Buy at Needham » 07:21
09/29/20
09/29
07:21
09/29/20
07:21
STOK

Stoke Therapeutics

$34.77 /

+0.31 (+0.90%)

Needham analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STOK Stoke Therapeutics
$34.77 /

+0.31 (+0.90%)

STOK Stoke Therapeutics
$34.77 /

+0.31 (+0.90%)

07:15 Today Needham
Stoke Therapeutics initiated with a Buy at Needham
06:12 Today JPMorgan
Stoke Therapeutics resumed with a Neutral at JPMorgan
02/07/20 Guggenheim
Guggenheim starts NeuBase Therapeutics at Buy with $13 price target
12/17/19 Wedbush
Stoke Therapeutics initiated with an Outperform at Wedbush
STOK Stoke Therapeutics
$34.77 /

+0.31 (+0.90%)

Hot Stocks
Summit Therapeutics sees cash, cash equivalents sufficient through Jan. 31, 2021 » 07:21
09/29/20
09/29
07:21
09/29/20
07:21
SMMT

Summit Therapeutics

$3.41 /

+0.04 (+1.19%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMMT Summit Therapeutics
$3.41 /

+0.04 (+1.19%)

SMMT Summit Therapeutics
$3.41 /

+0.04 (+1.19%)

03/19/20 H.C. Wainwright
Summit Therapeutics assumed with a Buy at H.C. Wainwright
SMMT Summit Therapeutics
$3.41 /

+0.04 (+1.19%)

Recommendations
NXP Semiconductors price target raised to $140 from $130 at KeyBanc » 07:21
09/29/20
09/29
07:21
09/29/20
07:21
NXPI

NXP Semiconductors

$123.91 /

+4.1601 (+3.47%)

KeyBanc analyst John Vinh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXPI NXP Semiconductors
$123.91 /

+4.1601 (+3.47%)

NXPI NXP Semiconductors
$123.91 /

+4.1601 (+3.47%)

09/16/20 Needham
NXP Semiconductors price target raised to $150 from $140 at Needham
08/25/20
Fly Intel: Top five analyst initiations
08/25/20 Wells Fargo
Wells Fargo starts NXP at Overweight on automotive production recovery
08/25/20 Wells Fargo
NXP Semiconductors initiated with an Overweight at Wells Fargo
NXPI NXP Semiconductors
$123.91 /

+4.1601 (+3.47%)

NXPI NXP Semiconductors
$123.91 /

+4.1601 (+3.47%)

NXPI NXP Semiconductors
$123.91 /

+4.1601 (+3.47%)

NXPI NXP Semiconductors
$123.91 /

+4.1601 (+3.47%)

Earnings
Summit Therapeutics reports Q2 EPS (23c) vs. (21c) last year » 07:20
09/29/20
09/29
07:20
09/29/20
07:20
SMMT

Summit Therapeutics

$3.41 /

+0.04 (+1.19%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMMT Summit Therapeutics
$3.41 /

+0.04 (+1.19%)

SMMT Summit Therapeutics
$3.41 /

+0.04 (+1.19%)

03/19/20 H.C. Wainwright
Summit Therapeutics assumed with a Buy at H.C. Wainwright
Hot Stocks
AppHarvest, Novus Capital enter into definitive combination agreement » 07:19
09/29/20
09/29
07:19
09/29/20
07:19
NOVS

Novus Capital Corp.

$10.09 /

+0.04 (+0.40%)

AppHarvest and Novus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Concert Pharmaceuticals completes patient enrollment in CTP-692 trial » 07:19
09/29/20
09/29
07:19
09/29/20
07:19
CNCE

Concert Pharmaceuticals

$9.27 /

+0.32 (+3.58%)

Concert Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNCE Concert Pharmaceuticals
$9.27 /

+0.32 (+3.58%)

CNCE Concert Pharmaceuticals
$9.27 /

+0.32 (+3.58%)

03/30/20
Fly Intel: Top five analyst initiations
03/30/20 Jefferies
Concert Pharmaceuticals initiated with a Buy at Jefferies
02/27/20 Stifel
Concert Pharmaceuticals price target raised to $11 from $8 at Stifel
01/22/20 SunTrust
Concert Pharmaceuticals price target raised to $30 from $25 at SunTrust
CNCE Concert Pharmaceuticals
$9.27 /

+0.32 (+3.58%)

  • 28
    Jan
Hot Stocks
Papa John's reports preliminary Q3 North America comparable sales up 23.8% » 07:18
09/29/20
09/29
07:18
09/29/20
07:18
PZZA

Papa John's

$83.29 /

+1.62 (+1.98%)

Reports preliminary Q3…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PZZA Papa John's
$83.29 /

+1.62 (+1.98%)

PZZA Papa John's
$83.29 /

+1.62 (+1.98%)

08/25/20 Stephens
Papa John's August results 'a positive surprise,' says Stephens
08/07/20 CL King
Papa John's price target raised to $110 from $90 at CL King
08/07/20 Stephens
Papa John's price target raised to $108 from $94 at Stephens
08/07/20 BTIG
Papa John's price target raised to $115 from $95 at BTIG
PZZA Papa John's
$83.29 /

+1.62 (+1.98%)

PZZA Papa John's
$83.29 /

+1.62 (+1.98%)

PZZA Papa John's
$83.29 /

+1.62 (+1.98%)

Recommendations
Inovio vaccine delay 'disappointing, but understandable,' says Benchmark » 07:15
09/29/20
09/29
07:15
09/29/20
07:15
INO

Inovio

$12.13 /

-4.78 (-28.27%)

Benchmark analyst Aydin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INO Inovio
$12.13 /

-4.78 (-28.27%)

INO Inovio
$12.13 /

-4.78 (-28.27%)

09/28/20 Maxim
Maxim upgrades Inovio to Buy, says shares oversold after vaccine 'speed bump'
09/28/20 Maxim
Inovio upgraded to Buy from Hold at Maxim
09/28/20 Roth Capital
Inovio price target lowered to $8 from $11 at Roth Capital
09/28/20 RBC Capital
Inovio clinical hold adds another roadblock in vaccine race, says RBC Capital
INO Inovio
$12.13 /

-4.78 (-28.27%)

INO Inovio
$12.13 /

-4.78 (-28.27%)

INO Inovio
$12.13 /

-4.78 (-28.27%)

INO Inovio
$12.13 /

-4.78 (-28.27%)

Initiation
Stoke Therapeutics initiated with a Buy at Needham » 07:15
09/29/20
09/29
07:15
09/29/20
07:15
STOK

Stoke Therapeutics

$34.77 /

+0.31 (+0.90%)

Needham analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STOK Stoke Therapeutics
$34.77 /

+0.31 (+0.90%)

STOK Stoke Therapeutics
$34.77 /

+0.31 (+0.90%)

06:12 Today JPMorgan
Stoke Therapeutics resumed with a Neutral at JPMorgan
02/07/20 Guggenheim
Guggenheim starts NeuBase Therapeutics at Buy with $13 price target
12/17/19 Wedbush
Stoke Therapeutics initiated with an Outperform at Wedbush
11/12/19
Fly Intel: Top five analyst initiations
STOK Stoke Therapeutics
$34.77 /

+0.31 (+0.90%)

Hot Stocks
Big Lots jumps 6% to $50.50 after Q3 guidance exceeds estimates  07:15
09/29/20
09/29
07:15
09/29/20
07:15
BIG

Big Lots

$47.73 /

+1.25 (+2.69%)

 
ShowHide Related Items >><<
BIG Big Lots
$47.73 /

+1.25 (+2.69%)

BIG Big Lots
$47.73 /

+1.25 (+2.69%)

08/31/20 Loop Capital
Big Lots price target raised to $60 from $55 at Loop Capital
08/31/20 Deutsche Bank
Big Lots price target raised to $52 from $42 at Deutsche Bank
08/31/20 Barclays
Big Lots price target raised to $50 from $34 at Barclays
06/29/20
Fly Intel: Top five analyst upgrades
BIG Big Lots
$47.73 /

+1.25 (+2.69%)

BIG Big Lots
$47.73 /

+1.25 (+2.69%)

BIG Big Lots
$47.73 /

+1.25 (+2.69%)

BIG Big Lots
$47.73 /

+1.25 (+2.69%)

Hot Stocks
Marsh & McLennan CHRO Laurie Ledford, CIO Scott Gilbert to retire » 07:14
09/29/20
09/29
07:14
09/29/20
07:14
MMC

Marsh & McLennan

$114.52 /

+1.56 (+1.38%)

Marsh & McLennan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMC Marsh & McLennan
$114.52 /

+1.56 (+1.38%)

MMC Marsh & McLennan
$114.52 /

+1.56 (+1.38%)

09/17/20 Deutsche Bank
Arthur J. Gallagher price target raised to $125 from $120 at Deutsche Bank
08/21/20 BofA
Marsh & McLennan downgraded to Underperform from Neutral at BofA
08/21/20 BofA
Marsh & McLennan downgraded to Underperform from Neutral at BofA
08/05/20 Raymond James
Raymond James downgrades Willis Towers Watson with focus on merger
MMC Marsh & McLennan
$114.52 /

+1.56 (+1.38%)

Hot Stocks
Axsome Therapeutics announces $225M term loan facility with Hercules Capital » 07:14
09/29/20
09/29
07:14
09/29/20
07:14
AXSM

Axsome Therapeutics

$76.45 /

-0.51 (-0.66%)

, HTGC

Hercules Capital

$11.46 /

+0.18 (+1.60%)

Axsome Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$76.45 /

-0.51 (-0.66%)

HTGC Hercules Capital
$11.46 /

+0.18 (+1.60%)

AXSM Axsome Therapeutics
$76.45 /

-0.51 (-0.66%)

06:25 Today BofA
Axsome Therapeutics initiated with an Underperform at BofA
06:04 Today BofA
Axsome Therapeutics initiated with an Underperform at BofA
09/10/20 Morgan Stanley
Axsome Therapeutics initiated with an Overweight at Morgan Stanley
09/01/20 Guggenheim
Axsome's Alzheimer's agitation update better than expected, says Guggenheim
HTGC Hercules Capital
$11.46 /

+0.18 (+1.60%)

07/31/20 Compass Point
Hercules upgraded to Buy on credit performance at Compass Point
07/31/20 Compass Point
Hercules Capital upgraded to Buy from Neutral at Compass Point
07/20/20 Piper Sandler
Hercules Capital assumed with an Overweight at Piper Sandler
06/19/20 Janney Montgomery Scott
Hercules Capital upgraded to Buy at Janney Montgomery Scott
AXSM Axsome Therapeutics
$76.45 /

-0.51 (-0.66%)

HTGC Hercules Capital
$11.46 /

+0.18 (+1.60%)

  • 19
    Dec
AXSM Axsome Therapeutics
$76.45 /

-0.51 (-0.66%)

AXSM Axsome Therapeutics
$76.45 /

-0.51 (-0.66%)

Hot Stocks
Aleafia Health launches Cannabis 2.0 portfolio with 510 vape cartridges » 07:12
09/29/20
09/29
07:12
09/29/20
07:12
ALEAF

Aleafia Health

$0.00 /

+ (+0.00%)

Aleafia Health announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALEAF Aleafia Health
$0.00 /

+ (+0.00%)

ALEAF Aleafia Health
$0.00 /

+ (+0.00%)

ALEAF Aleafia Health
$0.00 /

+ (+0.00%)

Syndicate
Elbit Systems files shelf prospectus in Israel » 07:11
09/29/20
09/29
07:11
09/29/20
07:11
ESLT

Elbit Systems

$121.08 /

+1.33 (+1.11%)

Elbit Systems announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESLT Elbit Systems
$121.08 /

+1.33 (+1.11%)

ESLT Elbit Systems
$121.08 /

+1.33 (+1.11%)

01/27/20 Jefferies
Jefferies starts Elbit Systems at Buy with $185 price target
01/27/20 Jefferies
Elbit Systems initiated with a Buy at Jefferies
Recommendations
Methanex price target raised to $30 from $28 at RBC Capital » 07:11
09/29/20
09/29
07:11
09/29/20
07:11
MEOH

Methanex

$23.76 /

+1.47 (+6.59%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEOH Methanex
$23.76 /

+1.47 (+6.59%)

MEOH Methanex
$23.76 /

+1.47 (+6.59%)

09/18/20 Raymond James
Raymond James reiterates Outperform on Methanex on surging China spot methanol
09/08/20 Raymond James
Methanex upgraded to Outperform from Market Perform at Raymond James
08/05/20 Scotiabank
Scotiabank downgraded Eastman Chemical on valuation after outperformance
07/01/20 Barclays
Methanex price target raised to $18 from $16 at Barclays
MEOH Methanex
$23.76 /

+1.47 (+6.59%)

MEOH Methanex
$23.76 /

+1.47 (+6.59%)

Hot Stocks
U.S. Energy to acquire upstream assets in New Mexico, Wyoming for $500,000 » 07:10
09/29/20
09/29
07:10
09/29/20
07:10
USEG

U.S. Energy

$4.26 /

-0.01 (-0.23%)

U.S. Energy announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Recommendations
    Size, timing of Libre 3 'positive surprises' for Abbott, says Morgan Stanley » 07:10
    09/29/20
    09/29
    07:10
    09/29/20
    07:10
    ABT

    Abbott

    $104.48 /

    +1.04 (+1.01%)

    , DXCM

    DexCom

    $400.10 /

    -2.2 (-0.55%)

    , MDT

    Medtronic

    $103.62 /

    +0.44 (+0.43%)

    After Abbott (ABT)…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    ABT Abbott
    $104.48 /

    +1.04 (+1.01%)

    DXCM DexCom
    $400.10 /

    -2.2 (-0.55%)

    MDT Medtronic
    $103.62 /

    +0.44 (+0.43%)

    ABT Abbott
    $104.48 /

    +1.04 (+1.01%)

    09/28/20 Stifel
    Libre 3 CE Mark approval a 'positive surprise' for Abbott, says Stifel
    09/28/20 Piper Sandler
    Piper says DexCom's coming G7 introduction important as Abbott narrows gap
    09/11/20 Wolfe Research
    Abbott initiated with an Outperform at Wolfe Research
    08/31/20 Credit Suisse
    Abbott price target raised to $136 from $109 at Credit Suisse
    DXCM DexCom
    $400.10 /

    -2.2 (-0.55%)

    09/28/20 Piper Sandler
    Piper says DexCom's coming G7 introduction important as Abbott narrows gap
    08/11/20 Piper Sandler
    Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
    07/29/20 SVB Leerink
    DexCom price target raised to $485 from $465 at SVB Leerink
    07/29/20 Guggenheim
    DexCom price target raised to $500 from $395 at Guggenheim
    MDT Medtronic
    $103.62 /

    +0.44 (+0.43%)

    09/11/20 Wolfe Research
    Medtronic initiated with a Peer Perform at Wolfe Research
    08/26/20 Raymond James
    Medtronic price target raised to $115 from $107 at Raymond James
    08/26/20 BTIG
    Medtronic price target raised to $111 from $102 at BTIG
    08/26/20 Citi
    Medtronic price target raised to $120 from $108 at Citi
    ABT Abbott
    $104.48 /

    +1.04 (+1.01%)

    DXCM DexCom
    $400.10 /

    -2.2 (-0.55%)

    MDT Medtronic
    $103.62 /

    +0.44 (+0.43%)

    ABT Abbott
    $104.48 /

    +1.04 (+1.01%)

    DXCM DexCom
    $400.10 /

    -2.2 (-0.55%)

    MDT Medtronic
    $103.62 /

    +0.44 (+0.43%)

    ABT Abbott
    $104.48 /

    +1.04 (+1.01%)

    DXCM DexCom
    $400.10 /

    -2.2 (-0.55%)

    MDT Medtronic
    $103.62 /

    +0.44 (+0.43%)

    ABT Abbott
    $104.48 /

    +1.04 (+1.01%)

    MDT Medtronic
    $103.62 /

    +0.44 (+0.43%)

    Hot Stocks
    j2 Global to acquire RetailMeNot for $420M from Vericast » 07:10
    09/29/20
    09/29
    07:10
    09/29/20
    07:10
    JCOM

    j2 Global

    $70.33 /

    +0.905 (+1.30%)

    J2 Global announced that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    JCOM j2 Global
    $70.33 /

    +0.905 (+1.30%)

    JCOM j2 Global
    $70.33 /

    +0.905 (+1.30%)

    08/17/20 Citi
    j2 Global upgraded to Buy from Neutral at Citi
    08/12/20
    Fly Intel: Top five analyst upgrades
    08/11/20 RBC Capital
    j2 Global upgraded to Outperform from Sector Perform at RBC Capital
    08/11/20 RBC Capital
    j2 Global upgraded to Outperform from Sector Perform at RBC Capital
    JCOM j2 Global
    $70.33 /

    +0.905 (+1.30%)

    JCOM j2 Global
    $70.33 /

    +0.905 (+1.30%)

    Hot Stocks
    Sogou announces merger plan with Tencent » 07:10
    09/29/20
    09/29
    07:10
    09/29/20
    07:10
    SOGO

    Sogou

    $8.67 /

    +0.06 (+0.70%)

    , SOHU

    Sohu.com

    $18.04 /

    +0.99 (+5.81%)

    Sogou (SOGO) announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    SOGO Sogou
    $8.67 /

    +0.06 (+0.70%)

    SOHU Sohu.com
    $18.04 /

    +0.99 (+5.81%)

    SOGO Sogou
    $8.67 /

    +0.06 (+0.70%)

    08/10/20 Jefferies
    Sogou downgraded to Hold from Buy at Jefferies
    04/30/20 Goldman Sachs
    Sogou upgraded to Buy from on growth recovery expectations at Goldman Sachs
    04/30/20 Goldman Sachs
    Sogou upgraded to Buy from Neutral at Goldman Sachs
    03/10/20 Credit Suisse
    Sogou downgraded to Neutral from Outperform at Credit Suisse
    SOHU Sohu.com
    $18.04 /

    +0.99 (+5.81%)

    08/10/20 Citi
    Sohu.com price target raised to $32 from $10 at Citi
    08/03/20 Morgan Stanley
    Sohu.com named a Research Tactical Idea at Morgan Stanley
    07/31/20 Morgan Stanley
    Sohu.com upgraded to Equal Weight from Underweight at Morgan Stanley
    04/16/20 Citi
    Sohu.com upgraded to Buy from Neutral at Citi
    SOGO Sogou
    $8.67 /

    +0.06 (+0.70%)

    SOHU Sohu.com
    $18.04 /

    +0.99 (+5.81%)

    SOHU Sohu.com
    $18.04 /

    +0.99 (+5.81%)

    SOGO Sogou
    $8.67 /

    +0.06 (+0.70%)

    SOHU Sohu.com
    $18.04 /

    +0.99 (+5.81%)

    SOGO Sogou
    $8.67 /

    +0.06 (+0.70%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.